BRPI0010150B8 - solução oral de prucalopride - Google Patents

solução oral de prucalopride

Info

Publication number
BRPI0010150B8
BRPI0010150B8 BRPI0010150A BR0010150A BRPI0010150B8 BR PI0010150 B8 BRPI0010150 B8 BR PI0010150B8 BR PI0010150 A BRPI0010150 A BR PI0010150A BR 0010150 A BR0010150 A BR 0010150A BR PI0010150 B8 BRPI0010150 B8 BR PI0010150B8
Authority
BR
Brazil
Prior art keywords
oral solution
prucalopride
prucalopride oral
pharmaceutically acceptable
acid addition
Prior art date
Application number
BRPI0010150A
Other languages
English (en)
Other versions
BR0010150A (pt
BRPI0010150B1 (pt
Inventor
Andre Josee De Proost Eddy
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BR0010150A publication Critical patent/BR0010150A/pt
Publication of BRPI0010150B1 publication Critical patent/BRPI0010150B1/pt
Publication of BRPI0010150B8 publication Critical patent/BRPI0010150B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Abstract

patente de invenção: "solução oral de prucalopride". a presente invenção refere-se a uma solução oral aquosa compreendendo prucalopride, ou seus sais ácidos de adição farmaceuticamente aceitáveis, com boas propriedades organolépticas.
BRPI0010150A 1999-04-29 2000-04-20 solução oral de prucalopride BRPI0010150B8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99201335 1999-04-29
PCT/EP2000/003739 WO2000066170A1 (en) 1999-04-29 2000-04-20 Prucalopride oral solution

Publications (3)

Publication Number Publication Date
BR0010150A BR0010150A (pt) 2002-01-15
BRPI0010150B1 BRPI0010150B1 (pt) 2015-06-23
BRPI0010150B8 true BRPI0010150B8 (pt) 2021-05-25

Family

ID=8240160

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0010150A BRPI0010150B8 (pt) 1999-04-29 2000-04-20 solução oral de prucalopride

Country Status (36)

Country Link
US (1) US6413988B1 (pt)
EP (1) EP1176982B1 (pt)
JP (1) JP4773619B2 (pt)
KR (1) KR100669175B1 (pt)
CN (1) CN1165345C (pt)
AR (1) AR023815A1 (pt)
AT (1) ATE254929T1 (pt)
AU (1) AU770073B2 (pt)
BG (1) BG65061B1 (pt)
BR (1) BRPI0010150B8 (pt)
CA (1) CA2371178C (pt)
CZ (1) CZ294070B6 (pt)
DE (1) DE60006799T2 (pt)
DK (1) DK1176982T3 (pt)
EA (1) EA003904B1 (pt)
EE (1) EE05264B1 (pt)
ES (1) ES2211546T3 (pt)
HK (1) HK1045950B (pt)
HR (1) HRP20010764B1 (pt)
HU (1) HU228924B1 (pt)
ID (1) ID30397A (pt)
IL (2) IL146152A0 (pt)
JO (1) JO2181B1 (pt)
MX (1) MXPA01010953A (pt)
MY (1) MY119880A (pt)
NO (1) NO331448B1 (pt)
NZ (1) NZ515119A (pt)
PL (1) PL195674B1 (pt)
PT (1) PT1176982E (pt)
SI (1) SI1176982T1 (pt)
SK (1) SK284847B6 (pt)
TR (1) TR200103121T2 (pt)
TW (1) TW592709B (pt)
UA (1) UA68426C2 (pt)
WO (1) WO2000066170A1 (pt)
ZA (1) ZA200108820B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050063998A1 (en) * 1999-10-26 2005-03-24 Francois Marc Karel Jozef Oral solution containing galantamine and a sweetening agent
CA2428386A1 (en) * 2000-11-24 2002-05-30 Janssen Pharmaceutica N.V. Use of a triple combination comprising a 5ht3 antagonist, a 5ht4 agonist and a laxative for promoting intestinal lavage
EP1467991B1 (en) 2002-01-16 2005-05-18 Janssen Pharmaceutica N.V. Prucalopride-n-oxide
JP4526247B2 (ja) * 2002-07-08 2010-08-18 第一三共株式会社 経口用セファロスポリン製剤
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
MX2007001477A (es) 2004-08-12 2007-10-10 Sapphire Therapeutics Inc Metodo para la estimulacion de la motilidad del sistema gastrointenstinal, que usa secretagogos de la hormona del crecimiento.
GB201103397D0 (pt) 2011-02-28 2011-04-13 Shire Movetis N V
US8568747B1 (en) 2012-10-05 2013-10-29 Silvergate Pharmaceuticals, Inc. Enalapril compositions
US9463183B1 (en) 2015-10-30 2016-10-11 Silvergate Pharmaceuticals, Inc. Lisinopril formulations
US9669008B1 (en) 2016-03-18 2017-06-06 Silvergate Pharmaceuticals, Inc. Enalapril formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
GB9005014D0 (en) * 1990-03-06 1990-05-02 Janssen Pharmaceutica Nv N.(4.piperidinyl)(dihydrobenzofuran or dihydro.2h.benzopyran)carboxamide derivatives
JPH05163154A (ja) * 1991-12-13 1993-06-29 Kanebo Ltd 経口液剤
TW490465B (en) * 1994-11-24 2002-06-11 Janssen Pharmaceutica Nv Enterokinetic benzamide, the preparation process and the pharmaceutical compositions thereof
AU770580B2 (en) * 1998-11-23 2004-02-26 Janssen Pharmaceutica N.V. Use of prucalopride for the manufacture of a medicament for the treatment of dyspepsia

Also Published As

Publication number Publication date
PL195674B1 (pl) 2007-10-31
WO2000066170A1 (en) 2000-11-09
JP2002543161A (ja) 2002-12-17
DK1176982T3 (da) 2004-03-29
NZ515119A (en) 2003-05-30
CN1165345C (zh) 2004-09-08
KR100669175B1 (ko) 2007-01-17
NO20014794D0 (no) 2001-10-02
EA003904B1 (ru) 2003-10-30
DE60006799D1 (de) 2004-01-08
MXPA01010953A (es) 2002-05-06
HUP0202324A3 (en) 2003-03-28
HUP0202324A2 (hu) 2002-12-28
AU770073B2 (en) 2004-02-12
TW592709B (en) 2004-06-21
NO20014794L (no) 2001-10-02
AU4913700A (en) 2000-11-17
DE60006799T2 (de) 2004-09-23
CA2371178C (en) 2008-03-25
BG106031A (en) 2002-05-31
IL146152A (en) 2006-12-31
BR0010150A (pt) 2002-01-15
US6413988B1 (en) 2002-07-02
EA200101150A1 (ru) 2002-04-25
EE05264B1 (et) 2010-02-15
EP1176982B1 (en) 2003-11-26
SI1176982T1 (en) 2004-04-30
SK15192001A3 (sk) 2002-03-05
HU228924B1 (en) 2013-06-28
HRP20010764B1 (en) 2011-01-31
BRPI0010150B1 (pt) 2015-06-23
IL146152A0 (en) 2002-07-25
ZA200108820B (en) 2003-01-27
SK284847B6 (sk) 2006-01-05
NO331448B1 (no) 2012-01-02
ATE254929T1 (de) 2003-12-15
BG65061B1 (bg) 2007-01-31
ID30397A (id) 2001-11-29
ES2211546T3 (es) 2004-07-16
KR20020004972A (ko) 2002-01-16
CA2371178A1 (en) 2000-11-09
PL352062A1 (en) 2003-07-28
MY119880A (en) 2005-07-29
HK1045950B (zh) 2005-05-27
EP1176982A1 (en) 2002-02-06
AR023815A1 (es) 2002-09-04
UA68426C2 (uk) 2004-08-16
JO2181B1 (en) 2003-04-23
EE200100539A (et) 2002-12-16
PT1176982E (pt) 2004-04-30
CN1348386A (zh) 2002-05-08
TR200103121T2 (tr) 2002-05-21
CZ20013735A3 (cs) 2002-02-13
JP4773619B2 (ja) 2011-09-14
HRP20010764A2 (en) 2002-12-31
HK1045950A1 (en) 2002-12-20
CZ294070B6 (cs) 2004-09-15

Similar Documents

Publication Publication Date Title
DE50011582D1 (de) Neuartige dicarbonsäurederivate mit pharmazeutischen eigenschaften
ATE299134T1 (de) Neuartige aminodicarbonsäurederivate mit pharmazeutischen eigenschaften
EA200301165A1 (ru) Лекарственное средство на основе оксикодона
DE60039291D1 (de) Camptothecinanaloge und deren zubereitungsmethoden
BG106158A (en) New use of compounds as antibacterial agents
CA2391076A1 (en) Solutions containing epinastin
PL374325A1 (en) Succinic acid salts of 5,8,14-triazatetracyclo[10.3.1.0 2,11 .0 4,9 ]-hexadeca-2(11),3,5,7,9,-pentaene and pharmaceutical compositions thereof
AU6945491A (en) Pimobendan compositions
BRPI0010150B8 (pt) solução oral de prucalopride
BR0012696A (pt) Composição oftálmica
PL346764A1 (en) New oral formulation for 5-ht4
DE60205888D1 (de) Das citrat-salz des 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaens
BR0104358A (pt) Formulações de taxana tendo solubilidade aperfeiçoada
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
CA2399709A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid and/or physiologically compatible salts thereof for producing a medicament for treating cancers
ITTO20000674A0 (it) Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca.
NO20013544L (no) Middel for å behandle Parkinsons sykdom samt anvendelse derav
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
ITRM20010048A0 (it) Metodo per preparare soluzioni acquose fisiologicamente accettabili esoluzioni cosi' ottenute.
CA2436537A1 (en) Pharmaceutical compositions comprising tiotropium salts and antihistamines
EP1236712A4 (en) Amidinophenylpyruvic acid DERIVATIVE
IL160162A0 (en) Salts of substituted 1,2,3,4,-tetrahydroisoquinolie-2-carboxylic acid derivatives
SI1086695T1 (en) Antiviral compositions comprising yohimbine as active principle
SE9902674D0 (sv) New composition

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/06/2015, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 20/04/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 20/04/2020